N-Methyl-N-((1-methyl-5-(3-(piperidin-1-yl)propoxy)-1H-benzo[d]imidazol-2-yl)methyl)prop-2-yn-1-amine (MBA-159), a new multitarget small molecule for the therapy of Alzheimer's disease

View Dataset
Bautista-Aguilera, Óscar M.T.;Manik, Aleksandra;Diez-Iriepa, Daniel;Szałaj, Natalia;Zaręba, Paula;Więckowska, Anna;Żmudzki, Paweł;Honkisz-Orzechowska, Ewelina;Knez, Damijan;Gobec, Stanislav;Sałat, Kinga;Martínez-Alonso, Borja;Guarnizo-Herrero, Víctor;DuránTorrado, Guillermo;Torrado-Salmerón, Carlos;Bellver-Sanchis, Aina;Nsiona-Defise, Inaya;Ribalta-Vilella, Marta;Pallàs, Mercè;López-Muñoz, Francisco;Griñán-Ferré, Christian;Marco-Contelles, José;Iriepa, Isabel

Description

  1. Molecular modeling studies of compound 7 comparing with Contilisant….........................................................................................................S2-S19 2. ADME of MBA-159…………………………………………………………..S19-S20 3. IR, NMR and MS spectra of MBA-159 and intermediates in its synthesis…………………………………………………………………...S21-S33 4. Table S3………………………………………………………………………..S34 5. References……………………………………………………………………..S35

Citations (0)

Mentions (0)

Metrics

Dataset Index

0.4

FAIR Score

69%

Citations

0

Mentions

0

Metrics Over Time

Publication Details

DOI

Publisher

Elsevier

License

openAccess

Assigned Domain

Subfield

Organic Chemistry

Field

Chemistry

Domain

Physical Sciences

Confidence Score

20%

Source

Scholar Data Model

Normalization Factors

FT

57.69

CTw

1.00

MTw

1.00